OrthoPediatrics Execs to Present at Canaccord Growth Conference

  • OrthoPediatrics CEO Dave Bailey and CFO Fred Hite to participate in fireside chat at Canaccord Genuity conference on August 12, 2026.
  • Event scheduled for 9:00 am ET; webcast available via OrthoPediatrics investor relations site.
  • Company markets over 90 pediatric orthopedic systems across trauma, scoliosis, and sports medicine categories.
  • Products distributed in the U.S. and 75+ countries globally.

OrthoPediatrics' participation in the Canaccord conference underscores its strategy of maintaining a specialized focus within pediatric orthopedics, a segment that has seen increasing demand but faces consolidation pressures. The company's comprehensive product portfolio positions it as a key player, though its ability to sustain growth will depend on execution in both domestic and international markets.

Market Positioning
How OrthoPediatrics will leverage this platform to emphasize its niche focus on pediatric orthopedics amid broader medtech consolidation trends.
Investor Sentiment
Whether the presentation will address concerns about competitive pressures in the specialized pediatric orthopedic space.
Geographic Expansion
The pace at which OrthoPediatrics can scale its international distribution network beyond current 75+ countries.